GoHealth, Inc. (GOCO) Revenue History
Annual and quarterly revenue from 2018 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
GOCO Revenue Growth
Revenue Breakdown (FY 2024)
GOCO's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
GOCO Revenue Analysis (2018–2024)
As of May 8, 2026, GoHealth, Inc. (GOCO) generated trailing twelve-month (TTM) revenue of $738.3 million, reflecting significant decline in growth of -71.1% year-over-year. The most recent quarter (Q3 2025) recorded $34.2 million in revenue, down 63.7% sequentially.
Looking at the longer-term picture, GOCO's 5-year compound annual growth rate (CAGR) stands at +8.2%, indicating steady revenue expansion. The company achieved its highest annual revenue of $1.06 billion in 2021.
Revenue diversification analysis shows GOCO's business is primarily driven by Commission (100%). With over half of revenue concentrated in Commission, the company maintains significant focus in this area while developing other growth vectors.
When compared to Financial Services sector peers including SLQT (+10.3% YoY), EHTH (-4.3% YoY), and EHC (+10.0% YoY), GOCO has underperformed the peer group in terms of revenue growth. Compare GOCO vs SLQT →
GOCO Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| GOCOCurrent | $738M | -71.1% | +8.2% | -0.9% | |
 SLQT | $1.5B | +10.3% | +23.6% | 4.5% | |
 EHTH | $554M | -4.3% | -1.0% | 12.4% | |
 EHC | $5.9B | +10.0% | +10.7% | 17.7% | |
 ACHC | $3.3B | +6.8% | +9.7% | 11.7% | |
 HIMS | $2.3B | +59.0% | +73.6% | 5.2% |
GOCO Historical Revenue Data (2018–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $798.9M | +8.7% | $668.3M | 83.7% | $-7,047,000 | -0.9% |
| 2023 | $734.7M | +16.3% | $575.7M | 78.4% | $-81,681,000 | -11.1% |
| 2022 | $631.7M | -40.5% | $444.0M | 70.3% | $-318,666,000 | -50.4% |
| 2021 | $1.06B | +21.1% | $823.1M | 77.5% | $-489,447,000 | -46.1% |
| 2020 | $877.4M | +62.6% | $678.1M | 77.3% | $-64,546,000 | -7.4% |
| 2019 | $539.5M | +138.5% | $369.9M | 68.6% | $-32,777,000 | -6.1% |
| 2018 | $226.2M | - | $146.6M | 64.8% | $28.8M | 12.7% |
See GOCO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GOCO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GOCO vs BRK-A
Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonGOCO — Frequently Asked Questions
Quick answers to the most common questions about buying GOCO stock.
Is GOCO's revenue growth accelerating or slowing?
GOCO revenue declined -71.1% year-over-year, contrasting with the 5-year CAGR of +8.2%. TTM revenue fell to $738M. This reverses the prior growth trend.
What is GOCO's long-term revenue growth rate?
GoHealth, Inc.'s 5-year revenue CAGR of +8.2% reflects the variable expansion pattern. Current YoY growth of -71.1% is below this long-term average.
How is GOCO's revenue distributed by segment?
GOCO reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2024 are available for download. Segment mix reveals concentration and diversification trends.